Department of Ophthalmology (CRD, AGL), Cullen Eye Institute, Baylor College of Medicine, Houston, Texas; Blanton Eye Institute (ATK, BAAO, AGL), Houston Methodist Hospital, Houston, Texas; and Departments of Ophthalmology, Neurology, and Neurosurgery (AGL), Weill Cornell Medicine, New York, New York; Department of Ophthalmology (AGL), University of Texas Medical Branch, Galveston, Texas; Department of Ophthalmology (AGL), UT MD Anderson Cancer Center, Houston, Texas; Department of Ophthalmology (AGL), Texas A and M College of Medicine, College Station, Texas; Department of Ophthalmology (AGL), University of Iowa Hospitals and Clinics, Iowa City, Iowa; Department of Ophthalmology (AGL), University of Buffalo, Buffalo, New York.
J Neuroophthalmol. 2020 Sep;40(3):e31-e48. doi: 10.1097/WNO.0000000000000950.
To describe the various neuro-ophthalmic presentations, key exam features, and clinical findings associated with 5 common primary and secondary intracranial malignancies.
Retrospective PubMed search and review of published case reports, case series, observational studies, book chapters, and review articles examining the neuro-ophthalmic features of intracranial malignancies including primary glial neoplasms (e.g., glioblastoma multiforme), primary and secondary lymphoma, intracranial metastases, carcinomatous/lymphomatous meningitis, and intracranial germ cell tumors. The search strategy used to perform the retrospective review included the aforementioned tumor type (e.g., glioblastoma multiforme) and the following terms and Boolean operators: AND ("visual loss" OR "papilledema" OR "diplopia" OR "ophthalmoplegia" or "neuro-ophthalmology" OR "proptosis").
The rate of growth and the location of an intracranial tumor are essential factors in determining the neuro-ophthalmic presentation of certain intracranial malignancies. Primary malignant brain glial neoplasms commonly present with visual afferent complaints (e.g., unilateral or bilateral visual acuity or visual field defects, bitemporal or homonymous hemianopsia), pupil abnormalities (relative afferent pupillary defect), and optic atrophy or papilledema. Primary intraocular lymphoma (with or without central nervous system lymphoma) typically presents as a painless bilateral vitritis. Secondary intracranial malignancies have variable afferent and efferent visual pathway presentations. Carcinomatous/lymphomatous meningitis is associated with diplopia (e.g., multiple ocular motor cranial neuropathies with or without vision loss from papilledema or compressive/infiltrative optic neuropathy). Intracranial germ cell tumors can present with a chiasmal syndrome or dorsal midbrain syndrome.
Intracranial malignancies can present with neuro-ophthalmic symptoms or signs depending on topographical localization. Specific neuro-ophthalmic presentations are associated with different malignant intracranial tumors. Clinicians should be aware of the common malignant intracranial tumors and their associated clinical presentations in neuro-ophthalmology.
描述 5 种常见原发性和继发性颅内恶性肿瘤的各种神经眼科表现、关键检查特征和临床发现。
通过回顾性 PubMed 搜索和审查已发表的病例报告、病例系列、观察性研究、书籍章节和综述文章,研究包括原发性神经胶质瘤(例如多形性胶质母细胞瘤)、原发性和继发性淋巴瘤、颅内转移瘤、癌性/淋巴瘤性脑膜炎和颅内生殖细胞瘤在内的颅内恶性肿瘤的神经眼科特征。进行回顾性审查的搜索策略包括上述肿瘤类型(例如多形性胶质母细胞瘤)和以下术语和布尔运算符:AND(“视力丧失”或“视乳头水肿”或“复视”或“眼肌麻痹”或“神经眼科”或“眼球突出”)。
颅内肿瘤的生长速度和位置是确定某些颅内恶性肿瘤神经眼科表现的重要因素。原发性恶性脑胶质肿瘤通常表现为视觉传入性主诉(例如单侧或双侧视力或视野缺损、双颞或同向偏盲)、瞳孔异常(相对传入性瞳孔缺陷)和视神经萎缩或视乳头水肿。原发性眼内淋巴瘤(伴或不伴中枢神经系统淋巴瘤)通常表现为无痛性双侧葡萄膜炎。继发性颅内恶性肿瘤的传入和传出视觉通路表现各不相同。癌性/淋巴瘤性脑膜炎与复视相关(例如伴有或不伴有视力丧失的多眼运动颅神经麻痹,由视乳头水肿或压迫/浸润性视神经病变引起)。颅内生殖细胞瘤可表现为视交叉综合征或中脑背侧综合征。
颅内恶性肿瘤可根据部位定位出现神经眼科症状或体征。特定的神经眼科表现与不同的恶性颅内肿瘤相关。临床医生应了解常见的恶性颅内肿瘤及其在神经眼科中的相关临床表现。